To access this element change to forms mode OFF
Grant Award View - GA259015
Are calcium channel blockers associated with breast cancer? Assessing...
GA ID:
GA259015
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Mar-2022
Publish Date:
25-Jul-2022
Category:
Medical Research
Grant Term:
1-Jul-2022 to 30-Jun-2025
Value (AUD):
$1,107,757.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Clinical Trials and Cohort Studies
Grant Activity:
Are calcium channel blockers associated with breast cancer? Assessing the impact of long-term use in large longitudinal cohorts
Purpose:
Breast cancer is the commonest cancer in women. Calcium channel blockers (CCBs) are frequently used worldwide to treat high blood pressure. A link between use of CCBs and breast cancer has been proposed with mixed findings in North American, European and Asian women. No data exist for Australian women or across populations. Since 1 in 8 Australian women will be diagnosed with breast cancer by age 85 years, it is important to determine whether this risk is increased by the use of CCBs.
GO ID:
GO Title:
NHMRC Clinical Trials and Cohort Studies Grants 2021 for funding mid-2022
Internal Reference ID:
2022/GNT2014896
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Curtin University
Recipient ABN:
99 143 842 569
Grant Recipient Location
Suburb:
Bentley
Town/City:
Bentley
Postcode:
6102
State/Territory:
WA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, WA, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, NETHERLANDS